Vital Stats From Our Heart Failure and Electrophysiology Programs
Check out this graphic recap of our latest volume and outcomes data in heart transplant, LVAD use, arrhythmia ablation, lead extractions and more.
Vital Stats From Our Heart Failure and Electrophysiology Programs
Our latest volume and outcomes data in two key subspecialty areas
Below we share recent volumes and clinical outcomes from two programs in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: heart failure and recovery, and electrophysiology and cardiac pacing.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
HEART FAILURE AND RECOVERY
2022 VOLUMES
66 Number of heart transplants, including 5 in pediatric patients and 1 heart/lung transplant
72 Number of left ventricular assist device (LVAD) implantations
312 Number of patient referrals for advanced heart failure
HEART TRANSPLANT
40% lower Best estimate of Cleveland Clinic’s risk of 1-year graft failure vs. the national average
49% lower Best estimate of Cleveland Clinic’s risk of 3-year graft failure vs. the national average
(Source: Scientific Registry of Transplant Recipients program report of 1/5/23)
LVAD IMPLANTATION
246 Number of LVAD implants over the past 3 years (97 in 2020, 77 in 2021, 72 in 2022), among the highest volumes in the United States
87.5% 1-year post-implant survival, primary LVADs (vs. 86.3% STS Intermacs survival)*
87.6% 1-year post-implant survival, continuous-flow LVADs for destination therapy (vs. 83.2% STS Intermacs survival)*
*For the period 7/1/21-12/31/22.
(Source: Society of Thoracic Surgeons [STS] Intermacs Quarterly Quality Assurance Report, 2022 Q4)
ELECTROPHYSIOLOGY (EP)
OVERALL VOLUME
30,926 EP lab procedure volume, 2018-2022
6,434 EP lab procedure volume, 2022
LEAD EXTRACTION
861 Lead extraction procedures, 2018-2022
95.9% Clinical success rate for lead extractions
0.12% In-hospital mortality, vs. benchmark of 1.2% (Kusumoto et al., Heart Rhythm. 2017)
ATRIAL FIBRILLATION ABLATION
6,125 Atrial fibrillation ablations, 2018-2022
1.78% Major complication rate, vs. benchmark of 2.5% (Hsu et al., J Am Coll Cardiol. 2023)
VENTRICULAR ARRHYTHMIA ABLATION
1,318 Ventricular arrhythmia ablations, 2018-2022
3.9% Major complication rate, vs. benchmark of 10% (Cronin et al., Heart Rhythm. 2020)
LEFT ATRIAL APPENDAGE OCCLUSION (LAAO)
904 Watchman™ and Amplatzer Amulet™ devices placed for LAAO procedures (inclusive of EP and interventional cases), 2018-2022
2.2% Major complication rate within 7 days of LAAO device implant, vs. benchmark of 2.7-8.7% in published trials (Boersma et al., Eur Heart J. 2016)
For more data like this, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.